RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

Augment Investments

Company

Assets

Owners

+ Augment Investments

According to the Cyprus register of legal entities, the holders of Augment Investments Ltd shares are Viktor Kharitonin (70%), registered in the British Virgin Islands Hiolot Holdings Ltd (0.05%), and Kalita Business House Management Company (29.94%, the ultimate beneficiary is Andrei Toporov, in 2013 he was listed as a member of the Board of Directors of Pharmstandart).

Augment Investments consolidated 100% of Pharmstandard in 2016. Then the Cypriot company forcibly bought shares from minority shareholders, who subsequently sued it 542 million rubles, believing that the transaction was carried out at a reduced price. In early 2018, Augment Investments is challenging the court's decision in an appeal.

2023

Repurchase Option Agreement for the Purchase of Henkel Assets in Russia

By April 2023, Henkel had agreed with the buyer of its Russian assets - a consortium of investors that includes Augment Investments, Kismet Capital Group and Elbrus Services - about a buyback option, citing the company's CFO Marco Liberty told Reuters.

2022

The authorities did not agree on the sale of the manufacturer of office paper "Snow Maiden" to billionaire Kharitonin

As it became known on December 19, 2022, the deal to sell the main asset of the Austrian Mondi group in Russia - Mondi Syktyvkar LPK (Mondi SLPK) in Komi - Augment Investments Limited, owned by co-owner of Pharmstandard Viktor Kharitonin, did not take place. Read more here.

Purchase of the plant "Mondi Syktyvkar LPK" for 1.5 billion euros

In August 2022, the Austrian group Mondi, which produces paper under the Snegurochka brand, announced the sale of Russian assets to Augment Investments Limited, co-owner of Pharmstandart, billionaire Viktor Kharitonin. The value of the transaction is 1.5 billion euros, its perimeter includes Mondi Syktyvkar LPK (the largest pulp and paper producer in Russia, which produces Snegurochka office paper) together with two subsidiaries. Read more here.